Allergy and Immunology 2021
DOI: 10.1183/13993003.congress-2021.oa2834
|View full text |Cite
|
Sign up to set email alerts
|

Clinical consequences and longitudinal outcomes in PiMZ heterozygous a1-antitrypsin deficiency smokers from SPIROMICS

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles